Modulators of Toll-Like Receptor (TLR) Signaling

被引：8

作者：

Spyvee, Mark ^{[1
]}

Hawkins, Lynn D. ^{[1
]}

Ishizaka, Sally T. ^{[1
]}

机构：

[1] Eisai Inc, Frontier Prod Creat Unit, Andover, MA 01810 USA

来源：

ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 45 | 2010年 / 45卷

关键词：

PLASMACYTOID DENDRITIC CELL; DOUBLE-STRANDED-RNA; IRAK-4; INHIBITORS; STRUCTURAL BASIS; IMMUNOSTIMULATORY ACTIVITY; CRYSTAL-STRUCTURES; BACTERIAL-DNA; CPG-MOTIF; PART; ACTIVATION;

D O I：

10.1016/S0065-7743(10)45012-5

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：191 / +

页数：18

共 109 条

[1] Phase I, randomized, double-blind trial of 7-allyl-8-oxoguanosine (loxoribine) in advanced cancer [J].

Agarwala, SS ;

Kirkwood, JM ;

Bryant, J .

CYTOKINES CELLULAR & MOLECULAR THERAPY, 2000, 6 (04) :171-176

[2] Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].

Alexopoulou, L ;

Holt, AC ;

Medzhitov, R ;

Flavell, RA .

NATURE, 2001, 413 (6857) :732-738

[3] Innate immunity for biodefense: A strategy whose time has come [J].

Amlie-Lefond, C ;

Paz, DA ;

Connelly, MP ;

Huffnagle, GB ;

Dunn, KS ;

Whelan, NT ;

Whelan, HT .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (06) :1334-1342

[4] A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin [J].

Andersen-Nissen, Erica ;

Smith, Kelly D. ;

Bonneau, Richard ;

Strong, Roland K. ;

Aderem, Alan .

JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (02) :393-403

[5]

[Anonymous], [No title captured], Patent No. 2008030579

[6]

AUBIN E, 2009, Patent No. 2009130616

[7] TLR4 links podocytes with the innate immune system to mediate glomerular injury [J].

Banas, Miriam C. ;

Banas, Bernhard ;

Hudkins, Kelly L. ;

Wietecha, Tomasz A. ;

Iyoda, Masayuki ;

Bock, Elisabeth ;

Hauser, Peter ;

Pippin, Jeffrey W. ;

Shankland, Stuart J. ;

Smith, Kelly D. ;

Stoelcker, Benjamin ;

Liu, Gang ;

Groene, Hermann-Josef ;

Kraemer, Bernhard K. ;

Alpers, Charles E. .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (04) :704-713

[8] A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses [J].

Bartfai, T ;

Behrens, MM ;

Gaidarova, S ;

Pemberton, J ;

Shivanyuk, A ;

Rebek, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) :7971-7976

[9] Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition [J].

Bauer, S ;

Kirschning, CJ ;

Häcker, H ;

Redecke, V ;

Hausmann, S ;

Akira, S ;

Wagner, H ;

Lipford, GB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9237-9242

[10] The 'Ethereal' nature of TLR4 agonism and antagonism in the AGP class of lipid A mimetics [J].

Bazin, Helene G. ;

Murray, Tim J. ;

Bowen, William S. ;

Mozaffarian, Afsaneh ;

Fling, Steven P. ;

Bess, Laura S. ;

Livesay, Mark T. ;

Arnold, Jeffrey S. ;

Johnson, Craig L. ;

Ryter, Kendal T. ;

Cluff, Christopher W. ;

Evans, Jay T. ;

Johnson, David A. .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (20) :5350-5354

← 1 2 3 4 5 6 7 8 9 10 →